An increase in CK2 activity by the overexpression of CK2α catalytic subunit induced EMT in cancer cells even in the absence of TGFβ‐dependent canonical SMAD signaling (Ko et al., 2012), indicating that CK2 activation might be necessary and sufficient to induce EMT. The gene discussed is TGFB1; the disease is cancer.